Released : 05/01/2018 09:49

RNS Number : 0928B

Evgen Pharma PLC

05 January 2018

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Evgen Pharma plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

change in percentage of voting rights arising upon a new issue of shares by the issuer

ü

3. Full name of person(s) subject to the
notification obligation:

Enterprise Ventures Limited

4. Full name of shareholder(s) (if different from 3.):

South Yorkshire Investment Fund Limited

5. Date of the transaction and date on
which the threshold is crossed or
reached:

Total Voting Rights announcement of the issuer dated 2 January 2018

6. Date on which issuer notified:

4 January 2017

7. Threshold(s) that is/are crossed or
reached:

5%

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB00BSVYN304

3,772,949

3,772,949

3,772,949

3,772,949

Nil

4.04

Nil

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

None

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

% of voting rights

None

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,772,949

4.04%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease
to hold:

12. Date on which proxy holder will cease to hold
voting rights:

13. Additional information:

14. Contact name:

Enterprise Ventures Limited

15. Contact telephone number:

01772 270 570

This information is provided by RNS

The company news service from the London Stock Exchange


ENDHOLGCGDBRSGBGIU

Evgen Pharma plc published this content on 05 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 January 2018 09:59:03 UTC.

Original documenthttp://otp.investis.com/clients/uk/evgen_pharma/rns/regulatory-story.aspx?cid=1240&newsid=963557

Public permalinkhttp://www.publicnow.com/view/87DCCDCFC9901210EB2D4515CE33A04FD40F252C